News Industry News Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients January 30, 2025
News Industry News Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System May 08, 2024
News Industry News Abbott Announces New Data That Shows Artificial Intelligence Technology Can Help Doctors Better Determine Which Patients Are Having A Heart Attack September 10, 2019
News Industry News Jubilant DraxImage Inc. Receives CE Mark Certificate for Its Medical Device RUBY Rubidium Elution System™ (RbES) and Proprietary RUBY™ Consumable Accessories June 07, 2019
News Industry News Biofourmis' RhythmAnalytics™ Platform Receives FDA Clearance for AI-Based Automated Interpretation of Cardiac Arrhythmias April 30, 2019
News Industry News BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina April 25, 2018
News Industry News Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic September 25, 2017
News Industry News Medtronic Receives CE Mark for Attain Stability(TM) Quad MRI SureScan(TM) Active-Fixation Heart Lead August 22, 2017
News Industry News Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers May 11, 2017
News Industry News Siemens Healthineers and HeartFlow Collaborate to Provide Solution That Has Potential to Lower Cardiac Care Costs March 21, 2017
News Industry News FDA Approves Aortica Corporation to Supply AortaFit™ System for Starnes' Physician-Sponsored IDE Study January 27, 2016
News Industry News Medtronic Announces FDA Approval and Launch of World's First App-Based Remote Monitoring System for Pacemakers November 16, 2015
News Industry News Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes August 26, 2015
News Industry News Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan) July 07, 2015
News Industry News Interventional Cardiovascular Device Development: Considerations in Clinical Trial Implementation June 10, 2015
News Industry News DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists June 08, 2015
News Industry News Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S. August 25, 2014
News Industry News Volcano to Highlight New Technologies and Clinical Study Results at TCT 2012 October 19, 2012
News Industry News First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy November 08, 2011